Clinical Trial Update: Levothyroxine Supplementation for Heart Transplant Recipients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating levothyroxine supplementation in heart transplant recipients; currently recruiting. Sponsored by the University of California,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Infectious Complication of Organ Transplantation

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Heart Transplant Failure, Heart Transplant Infection | Phase 1 | Status: RECRUITING